Antitachycardia Pacing Helps With Upfront Delay in ICD Shocks Posted on October 3rd, 2024 by LEADconnection Post navigation Previous: Boston’s Empower leadless pacemaker demonstrates “excellent overall clinical performance” in MODULAR ATP studyNext: APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing
Boston’s Empower leadless pacemaker demonstrates “excellent overall clinical performance” in MODULAR ATP study Posted on September 26th, 2024 by LEADconnection Post navigation Previous: LBBAP limits hospital readmissions after TAVRNext: Antitachycardia Pacing Helps With Upfront Delay in ICD Shocks
LBBAP limits hospital readmissions after TAVR Posted on September 20th, 2024 by LEADconnection Post navigation Previous: FDA approves Boston Scientific leads for left bundle branch area pacingNext: Boston’s Empower leadless pacemaker demonstrates “excellent overall clinical performance” in MODULAR ATP study